HomeIOVA • NASDAQ
add
Iovance Biotherapeutics Inc
$2.27
Makalipas ang Oras ng Trabaho:(2.18%)+0.049
$2.32
Sarado: Set 12, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$2.42
Sakop ng araw
$2.27 - $2.43
Sakop ng taon
$1.64 - $12.50
Market cap
821.41M USD
Average na Volume
13.56M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 59.95M | 92.73% |
Gastos sa pagpapatakbo | 117.06M | 15.16% |
Net na kita | -111.66M | -14.99% |
Net profit margin | -186.25 | 40.34% |
Kita sa bawat share | -0.33 | 2.94% |
EBITDA | -104.71M | -12.06% |
Aktuwal na % ng binabayarang buwis | -1.81% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 301.18M | -26.99% |
Kabuuang asset | 907.44M | -5.90% |
Kabuuang sagutin | 208.95M | 6.73% |
Kabuuang equity | 698.49M | — |
Natitirang share | 361.85M | — |
Presyo para makapag-book | 1.19 | — |
Return on assets | -30.35% | — |
Return on capital | -36.16% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -111.66M | -14.99% |
Cash mula sa mga operasyon | -67.45M | 31.48% |
Cash mula sa pag-invest | 13.84M | -65.58% |
Cash mula sa financing | 13.23M | -91.34% |
Net change in cash | -39.64M | -141.95% |
Malayang cash flow | -12.18M | 77.07% |
Tungkol
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
Itinatag
2007
Headquarters
Website
Mga Empleyado
838
